Medpace Holdings, Inc. (MEDP) Average Return on Invested Capital (ROIC)
The current return on invested capital (roic) for Medpace Holdings, Inc. (MEDP) is N/A as of Thursday, June 18, 2026, shown against its trailing averages.
Average Return on Invested Capital (ROIC) Chart
MEDP Return on Invested Capital (ROIC) Averages
RETURN ON INVESTED CAPITAL (ROIC) CURRENT
N/A
RETURN ON INVESTED CAPITAL (ROIC) TTM
52.59%
RETURN ON INVESTED CAPITAL (ROIC) 3Y
46.08%
RETURN ON INVESTED CAPITAL (ROIC) 5Y
35.95%
RETURN ON INVESTED CAPITAL (ROIC) 10Y
22.88%
RETURN ON INVESTED CAPITAL (ROIC) 15Y
19.51%
RETURN ON INVESTED CAPITAL (ROIC) 20Y
19.51%
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle